Skip to main content

Sea anemone genes could spur advancements in regenerative medicine

sea anemone heart gene regeneration regenerative medicine
Image used with permission by copyright holder
In the future, artificial and transplanted organs may be things of the past as regenerative medicine becomes so advanced that a damaged heart or lung is simply regrown from cells already present.

That possibility is still far in the distance, but a new study out of the University of Florida could help pave the way. While examining the genes of the starlet sea anemone — an invertebrate capable of regenerating itself — a research team led by Mark Martindale discovered genes that are known to grow heart cells in humans.

Recommended Videos

The finding was surprising in part because anemones don’t have hearts or muscles, and yet Martindale knew they shared more in common with humans than might be expected.

“A group of us sequenced the genome of the anemone … about 10 years ago,” he told Digital Trends. “One of the super cool things we found was that this little sea anemone had more genes in common with human beings than all of the other so-called ‘model systems’ that 99 percent of the people in my field work on.”

Since these model systems — including fruit flies and nematodes — are nearer to humans on the evolutionary timescale, that finding suggested that they’ve lost genes along the way.

“It turns out that the number of genes you have does not seem to be a very good predictor of organismal complexity as we have traditionally interpreted it,” Martindale said.

Rather of the number of genes, the deciding factor may be the way they communicate with each other.

“One of the most important findings in this paper is not necessarily how many genes are involved in ‘heart’ formation, but how they are ‘wired-up.’” Martindale explained. “Genes control other genes in very complicated networks. Many people focus on genes that are involved in cell division … but not as many people have studied the differences in how these genes ‘talk’ to each other in animals that can regenerate versus those that can not regenerate.”

By understanding how genes communicate, the researchers hope that they can someday stimulate regenerative healing in the human body.

But there’s a lot of work to be done first. One of the big challenges will be determining whether certain mechanisms are species-specific or if they can be adapted. In vertebrates, for example, heart genes create “lockdown loops” that require them to perform functions related to their location in the body. Anemone genes don’t lockdown in such a way. It’s unclear whether this feature is fixed to anemone or if it can be activated in humans as well.

Dyllan Furness
Former Digital Trends Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Rivian offers $3,000 off select EVs to gasoline, hybrid vehicle drivers
Second-Gen Rivian R1S on a road

Early November typically kicks off the run-up to the Black Friday sales season, and this year, Rivian is betting it’s the perfect time to lure gasoline drivers toward its EVs.
If you own or lease a vehicle that runs on gasoline, which means even a hybrid vehicle, Rivian is ready to give you $3,000 off the purchase of one of its select fully electric vehicles -- no trade-in required.
The offer from the Irvine, California-based automaker extends to customers in the U.S. and Canada and runs through November 30, 2024. The program applies to Rivian 2025 R1S or R1T Dual Large, Dual Max, or Tri Max models purchased from R1 Shop.
Rivian’s new All-Electric Upgrade offer marks a change from a previous trade-in program that ran between April and June. There, owners of select 2018 gas-powered vehicles from Ford, Toyota, Jeep, Audi, and BMW could trade in their vehicle and receive up to $5,000 toward the purchase of a new Rivian.
This time, buyers of the R1S or R1T Rivian just need to provide proof of ownership or lease of a gas-powered or hybrid vehicle to receive the discount when they place their order.
Rivian is not going to be the only car maker offering discounts in November. Sluggish car sales from giants such as Stellantis and rising inventories of new cars due to improving supply chains suggest automakers and dealerships will be competing to offer big incentives through the year's end.
This follows several years of constrained supply following the COVID pandemic, which led to higher prices in North America.
According to CarEdge Insights, average selling prices for cars remain above what would be called affordable. But prices should continue improving along with rising inventories.
Stellantis brands are entering November with the most inventory, followed by GM and Ford, according to CarEdge. Toyota and Honda, meanwhile, have the least inventory, meaning they probably won’t be under pressure to offer big incentives.

Read more
AT&T, Voltpost bring internet connectivity to EV charging lampposts
att voltpost streetlight charging newlabdetroit 63

Move over, Supercharger network.

EV charging networks have been fast expanding across U.S. roads and highways over the past year, led by the likes of Electrify America, Tesla, and Chargescape, to name a few.

Read more
Volvo’s much-anticipated EX30 EV to reach U.S. before year end
Front three quarter view of the 2025 Volvo EX30.

Volvo is switching gears again, this time to accelerate deliveries of its much-anticipated EX30 subcompact electric SUV so that it reaches the U.S. before the end of 2024.

The Swedish automaker last summer had postponed the U.S. launch of the EX30 to 2025, citing “changes in the global automotive landscape." The move followed the Biden administration’s 100% import tariff on electric vehicles made in China.

Read more